Large‐Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real‐World Clinical Setting

BACKGROUND. Regorafenib improved the overall survival (OS) of patients with metastatic colorectal cancer (mCRC) who progress after standard therapies in two phase III trials. The present large‐scale prospective observational study evaluated the safety and effectiveness of regorafenib administered to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncologist
Egile Nagusiak: Yamaguchi, Kensei, Komatsu, Yoshito, Satoh, Taroh, Uetake, Hiroyuki, Yoshino, Takayuki, Nishida, Toshirou, Yamazaki, Naoya, Takikawa, Hajime, Morimoto, Takashi, Chosa, Masayuki, Sunaya, Toshiyuki, Hamada, Yoko, Muro, Kei, Sugihara, Kenichi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Inc. 2019
Gaiak:
Gastrointestinal Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656456/
https://ncbi.nlm.nih.gov/pubmed/30606885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0377
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak